Invention Grant
- Patent Title: Method of making patient specific anti-idiotype antibodies
-
Application No.: US15261084Application Date: 2016-09-09
-
Publication No.: US10221249B2Publication Date: 2019-03-05
- Inventor: David J. States , Carlos F. Santos
- Applicant: Affigen, LLC
- Applicant Address: US MO St. Louis
- Assignee: Affigen, LLC
- Current Assignee: Affigen, LLC
- Current Assignee Address: US MO St. Louis
- Agency: Womble Bond Dickinson (US) LLP
- Agent Danielle L. Herritt; Cristin H. Cowles
- Main IPC: C07K16/42
- IPC: C07K16/42 ; C07K16/28 ; C07K16/30 ; A61K39/00
Abstract:
The present disclosure relates to therapies for the treatment of tumor, autoimmune diseases, or other diseases. In some embodiments, the present disclosure can relate to subject-specific selection of humanized antibodies targeting clonal lineage specific marker proteins.
Public/Granted literature
- US20170073432A1 SEQUENCING-DIRECTED SELECTION OF TUMOR THERANOSTICS Public/Granted day:2017-03-16
Information query
